<DOC>
	<DOCNO>NCT02104180</DOCNO>
	<brief_summary>Evaluation non-inferiority TulleGras M.S.® versus Urgotul® pain associate removal wound dress care venous leg ulcer</brief_summary>
	<brief_title>Evaluation Pain Associated With Removal Wound Dressing During Care Venous Leg Ulcer . Comparison Efficacy Safety Two Dressings Urgotul TulleGras</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Subject inform objective , purpose , detail constraint study give his/her write informed consent . Male female subject . Subject least 45 year age . Subject present open venous leg ulcer . Age venous leg ulcer 1 month 12 month inclusive Inclusion Visit ( Visit 1 ) . Venous leg ulcer whose area 4 cm2 50 cm2 inclusive Inclusion Visit ( Visit 1 ) . Venous leg ulcer granulation phase 50 % area Inclusion Visit ( Visit 1 ) ; Related disease study : Venous leg ulcer surgery indicate surgical procedure plan within twelve week inclusion study ( Visit 1 ) . Venous leg ulcer start clean phase ; Fibrinous dry ulcer ( non exudative wound ) contrary highly exudative and/or hemorrhagic . Venous leg ulcer sign critical colonization clinically infect . Cancerous venous leg ulcer . Related subject : Subject present serious systemic disease , may lead premature termination study end twelve week treatment Follow Period . Subject medical history significant disease reveal history limit his/her participation prevent subject completing study . Subject present progressive neoplasm , treat radiotherapy chemotherapy immunosuppressant therapy highdose corticosteroid . Subject underwent surgery directly relate his/her venous disease two month prior Inclusion Visit ( Visit 1 ) . Subject poorly control diabetes . Subject present deep venous thrombosis 3 month prior Inclusion Visit ( Visit 1 ) . Subject confine bed . Woman childbearing potential ( NOT postmenopausal least 24 month NOT surgically sterilize ( tubal ligation ) NOT hysterectomized ) NOT routinely use adequate efficient hormonal contraception barrier method ( intrauterine device , diaphragm , combination condom spermicide ) prior trial . Subject whose ankle circumference , measure Inclusion Visit ( Visit 1 ) , great 32 cm ( &gt; 32 cm ) . Subject present symptomatic asymptomatic peripheral arterial disease , particularly distal systolic pressure index , measure Inclusion Visit ( Visit 1 ) , ≤0.8 ≥1.3 . Subject history allergic reaction ( ) one different component dressing contraindication use one dressing . Known history alcohol abuse drug abuse . Subject linguistically psychologically unable understand information give provide informed consent . Subject participate participate another clinical study within 4 week prior Inclusion Visit ( Visit 1 ) . Subject cover beneficiary Social Security system . Subject deprive freedom result legal administrative decision subject legal guardianship . Any reason , investigator 's opinion , prohibit inclusion subject study .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>non-inferiority</keyword>
	<keyword>randomize</keyword>
	<keyword>TulleGras</keyword>
	<keyword>Urgotul</keyword>
	<keyword>pain</keyword>
	<keyword>venous leg ulcer</keyword>
	<keyword>heal</keyword>
</DOC>